The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Acute myocarditis associated with COVID-19 vaccination: A case report
Open accessAbstract
Recently, new vaccine platforms-including mRNA vaccines for coronavirus disease 2019 (COVID-19) have been given emergency use authorization in Japan. Here, we present a rare case of myocarditis following a COVID-19 vaccine. In this case, myocarditis was confirmed by cardiac magnetic resonance imaging, endomyocardial biopsy, and troponin levels. The degree of myocardial inflammation in the endomyocardial biopsy samples was mild and the patient's clinical course was not severe. Although the pathology of myocarditis in this case was mild, further investigation would be needed. < Learning objective: Vaccination for coronavirus disease 2019 is advancing worldwide, but post-vaccination myocarditis is getting attention as a rare side effect. Although the myocarditis in this case was mild, the pathogenesis of the disease is unclear and needs to be thoroughly investigated in the vaccination.>
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“mRNA vaccines have been found to produce symptoms associated with myocarditis within 3 to 11 days after the second vaccine dose and to produce a mixed infiltrate (macrophages and lymphocytes) in EMB (Figure 2), which is the typical time course of inflammation based on histology from viral and autoimmune myocarditis in patients and animal models (eg, lymphocytic, giant cell myocarditis, and CVB3 my”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [197]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · cited 3×
“Some previous studies have also reported adverse events afer COVID-19 vaccination [3] .”
InfluentialInterim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
Sadoff, J., Le Gars, M., Shukarev, G., Heerwegh, D., Truyers, C., de Groot, A. M., Stoop, J., Tete, S., Van Damme, W., Leroux-Roels, I., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034201 · Cited by 1,208
Myocarditis following COVID-19 mRNA vaccination
Abu Mouch, S., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., Zoabi, M., Aisman, M., Goldschmid, N., & Berar Yanay, N. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.05.087 · Cited by 274
Research works printed but not linked: 7
- Zeng, 2020, First case of COVID-19 complicated with fulminant myocarditis: a case report and insights, Infection, 48, 773, 10.1007/s15010-020-01424-5 · DOI
- Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med, 46, 846, 10.1007/s00134-020-05991-x · DOI · Paper page
- Ferreira, 2018, Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations, J Am Coll Cardiol, 72, 3158, 10.1016/j.jacc.2018.09.072 · DOI · Paper page
- Rosner, 2021, Myocarditis temporally associated with COVID-19 vaccination, Circulation, 144, 502, 10.1161/CIRCULATIONAHA.121.055891 · DOI
- Muthukumar, 2021, In-depth evaluation of a case of presumed myocarditis following the second dose of COVID-19 mRNA vaccine, Circulation, 144, 487, 10.1161/CIRCULATIONAHA.121.056038 · DOI
- Verma, 2021, Myocarditis after Covid-19 mRNA vaccination, N Engl J Med, 385, 1332, 10.1056/NEJMc2109975 · DOI
- Choi, 2021, Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: Case report focusing on histopathological findings, J Korean Med Sci, 36, e286, 10.3346/jkms.2021.36.e286 · DOI
Cited by
COVID-19, Myocarditis and Pericarditis
Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 194
Metadata
- Authors
- Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., Yokoyama, T., & Kaneko, Y.
- Affiliations
- Gunma University (JP)
- Corresponding author
- Koitabashi, Norimichi
- ORCID
- Venue
- Journal of Cardiology Cases
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 25
- Issue
- 5
- Pages
- 285-288
- ISSN
- 1878-5409 (ISSN-L)
- PMC
- PMC8639400
- OpenAlex
- W4200527736
- Cited by
- 22
- References
- 3
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 3 · 2022: 13
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Cardiology Cases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (21K08022)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- acute myocarditis, COVID-19 vaccination, mRNA vaccines, vaccine adverse events, endomyocardial biopsy, cardiac magnetic resonance imaging, troponin, myocarditis, pathogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
